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Abstract 
Wearable devices to self-monitor physical activity have become popular with individuals and 
healthcare practitioners as a route to the prevention of chronic disease. It is not currently 
possible to reconcile feedback from these devices with activity recommendations because 
the guidelines refer to the amount of activity required on top of normal lifestyle activities (e.g., 
150 minutes of moderate-to-vigorous intensity activity per week over-and-above normal 
moderate-to-vigorous lifestyle activities). The aim of this study was to recalibrate the 
feedback from self-monitoring.  
We pooled data from four studies conducted between 2006 and 2014 in patients and 
volunteers from the community that included both sophisticated measures of physical activity 
and 10-year risk for cardiovascular disease and type 2 diabetes (n=305). We determined the 
amount of moderate-to-vigorous intensity activity that corresponded to FAO/WHO/UNU 
guidance for a required PAL of 1.75 (Total Energy Expenditure/Basal Metabolic Rate). 
Our results show that, at the UK median PAL, total moderate-to-vigorous intensity physical 
activity will be around 735 minutes per week (~11% of waking time). We estimate that a 4% 
increase in moderate-to-vigorous intensity activity will achieve standardised guidance from 
FAO/WHO/UNU and will require ~1000 minutes of moderate-to-vigorous intensity activity per 
week. 
This study demonstrates that feedback from sophisticated wearable devices is incompatible 
with current physical activity recommendations. Without adjustment, people will erroneously 
form the view that they are exceeding recommendations by several fold. A more appropriate 
target from self-monitoring that accounts for normal moderate-to-vigorous lifestyle activities is 
~1000 minutes per week, which represents ~15% of waking time. 
Key words: Physical activity status, physical activity recommendations, physical activity 
monitoring, physical activity energy expenditure, exercise. 
3 
Highlights 
 Many people are self-monitoring their physical activity in a way that was impossible 
in the past.  
 Current physical activity guidelines were not formulated with such technology in 
mind.  
 Our study shows that self-monitoring is not compatible with current activity 
guidelines. 
 An adjusted target for self-monitoring is ~ 1000 minutes of activity per week (~15% 
of waking time). 
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BACKGROUND 
There has been an explosion in the availability of wearable devices that allow people to self-
monitor and track their physical activity 1. Wearable technologies are enormously popular 
and it is estimated that in 2016 alone global sales will approach 100 million units 2. Thus, 
there are millions of people around the world who are beginning to self-monitor their physical 
activity in a way that was never possible in the past.  
These wearable technologies are a potentially very useful way for individuals to self-monitor 
and manage their physical activity as a route to the prevention of chronic disease 3 4. In 
addition, as the accuracy and affordability of these technologies has improved, they are 
beginning to play an increasingly important role in healthcare and public health 1.  
Based on our previous research 3 5 6, we suspected that many people will receive feedback 
from physical activity monitoring that is difficult to reconcile with recommended levels of 
physical activity from national agencies (e.g., The Department of Health in the UK, 7). The 
public as well as healthcare providers need to be equipped with an understanding of the 
output from these devices if they are to be used successfully to help support and/or monitor 
behaviour. 
The purpose of the present investigation was to clarify and recalibrate physical activity 
feedback from wearable technologies in order to reconcile differences with physical activity 
recommendations and thus provide guidance to help the public and healthcare practitioners 
interpret this potentially valuable information.  
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METHODS 
Design 
To ensure that this research was not prone to either device- or population-specific influences, 
we combined data from studies that used two very different devices for the collection of 
physical activity data and that also targeted different populations (including both the general 
public and patients recruited from primary care). We collated data from several studies that 
were conducted at the University of Bath between 2006 and 2014. In all studies, 
sophisticated measures of physical activity were employed to characterise participants and 
other measures were also included to enable the calculation of cardiovascular and type 2 
diabetes risk (QRISK and/or QDiabetes score). One analysis draws on studies that recruited 
men from the local community and used an expensive research-grade instrument for the 
assessment of physical activity energy expenditure (Comparison 1). The second analysis 
comes from a study that recruited patients from primary care and employed a commercially-
available physical activity monitor (Comparison 2). A key feature of this analysis is that the 
instruments used in both comparisons derive accurate estimates of physical activity in units 
of energy expenditure (kJ/min). Participants in all studies provided written informed consent. 
Comparison 1: Research-based physical activity monitor  
For comparison 1, we examined our previous projects to identify studies where we had both 
physical activity data and risk of cardiovascular disease and type 2 diabetes in middle-aged 
participants from the local community. We identified three studies and pooled these data to 
undertake the present comparison 8-10. The device employed to collect physical activity 
energy expenditure in these studies was a research instrument that uses synchronized 
accelerometry and heart rate with branched equation modelling (Actiheart, Cambridge 
Neurotechnology Ltd., Cambridge, UK) and has been shown to have excellent accuracy 11-14. 
Each device costs around £1000 ($1500 US) and it is unlikely that this specific instrument 
will ever be sold directly to the public. However, given the rate of technological progress, 
commercially-available wearable technologies will be likely to perform at a similar level in the 
near future.  
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In all three studies for comparison 1, participants were recruited from the local community via 
advertisement (National Health Service Research Ethics Committee reference numbers 
06/Q2001/30, 06/Q2001/105, and 11/SW/0193). Participants were non-smoking men who 
were not taking any medication and were aged 35 to 64 years (Table 1). In two studies 
(n=66), participants were only included if they self-reported low participation in structured 
exercise (i.e., two or fewer occasions of structured exercise lasting 30 minutes per week). 
One study recruited a sub-group of highly active volunteers who self-reported participation in 
at least 30 minutes of moderate intensity physical activity per day plus vigorous intensity 
exercise at least 3 times per week (n=12). In the remaining volunteers (n=23), no specific 
physical activity or exercise inclusion criteria were employed. 
Comparison 2: Commercially-available physical activity monitor 
For comparison 2, we undertook an analysis of physical activity data from patients recruited 
from primary care in the South West of the UK as part of the Mi-PACT trial (National Health 
Service REC reference number 13/SW/0179). The men and women in this study were 
recruited based on having moderate-to-high risk of cardiovascular disease or type 2 diabetes 
according to records in GP databases. The physical activity data were collected with a 
physical activity monitor that is already being sold and used widely by the public (BodyMedia 
FIT, BodyMedia Inc., Pittsburgh, PA). Importantly, unlike many other commercially-available 
devices, it is possible to extract raw minute-by-minute estimates of energy expenditure in 
order to undertake the necessary data processing to extract the key physical activity metrics 
required for our analysis (SenseWear® Pro 8.0, algorithm v5.2). Although this technology is 
available to the public as a commercial product, it has also been used in research studies 
and has excellent reported accuracy 15-20.  
The sample for this comparison represents the first 204 sequential patients who were 
screened as part of the Mi-PACT study 21. Briefly, this study recruited men and women from 
primary care aged 40-70 years at medium (³10 and <20%) or high (³20%) risk of 
cardiovascular disease and/or type II diabetes mellitus (based on QRISK or QDiabetes 
scores calculated from records in their GPs notes). People were excluded with existing 
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coronary heart disease, chronic kidney disease (stages 3-5), diabetes mellitus, stroke, heart 
failure and peripheral arterial disease. Participant characteristics are shown in Table 1. 
Physical Activity Energy Expenditure: Data Handling and Analysis 
Both physical activity instruments used in the current analysis are body mounted and collect 
data on a minute-by-minute basis (day and night). Weekly physical activity energy 
expenditure records for both comparisons were exported to Excel and processed in exactly 
the same way. To be included, physical activity data was required for at least 90% of a full 7-
day period. Missing data were allocated estimated energy expenditure equivalent to basal 
metabolic rate 22. We determined Physical Activity Level (PAL) as the product of Total Energy 
Expenditure/Basal Metabolic Rate 6 and time engaged in moderate intensity activity (> 3 
Metabolic Equivalents or METs) and vigorous intensity activity (> 6 METs), where one MET 
represents resting metabolic rate. The primary analysis focuses on total accumulated 
physical activity data  the supplementary section online includes an analysis using bouts of 
activity greater than 10 minutes (Additional File 3). 
QRISK and QDiabetes 
We used age, sex, ethnicity, smoking status, cholesterol/HDL ratio, systolic blood pressure 
and body mass index to estimate QRISK and QDiabetes scores for each participant using 
the combined QIntervention platform 23.  
Data analysis 
Statistical analysis was conducted in 2015. We used simple linear regression to determine 
the average amount of physical activity per week above 3 METs associated with a PAL of 
1.75  the level of physical activity recommended by the FAO/WHO/UNU 24. This model was 
applied to comparisons 1 and 2, separately, and to a pooled data set of all 305 participants. 
For simplicity, no study or participant characteristics were included in the models; this 
decision made no material difference to the estimates. Also, in the pooled model alone, we 
determined the amount of activity that an individual person would need to accumulate such 
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that the probability that their true PAL was ³1.75 was at least 95% (very likely;25). Using the 
standard error of the estimate obtained by regressing PAL on minutes per week >3 METS, 
we derived the minutes per week necessary for the lower limit of the 90% individual 
prediction interval for PAL to be 1.75. Applying a reference Bayesian approach, if the lower 
limit of the 90% confidence interval is 1.75 then the probability that this individuals true PAL 
is ³1.75 is 95% (area to the right of 1.75 = 0.95).  
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RESULTS 
As shown in Table 1, participants spent the majority of the time (~9000 minutes per week) 
engaged in activities below the moderate-to-vigorous intensity threshold of 3 METs (i.e., they 
spent most of their time engaged in sedentary activities, light intensity activities and sleep).  
Table 1 
Participant Characteristics 
Comparison 1 
Research 
Instrument 
(n=101) 
Comparison 2 
Commercial 
Instrument 
(n=204) 
Age, y 51 (6) 64 (6) 
Male Sex N (% sample) 101 (100) 134 (66) 
Height, m 1.79 (0.06) 1.71 (0.09) 
Weight, kg 88 (12) 84 (15) 
BMI, kg/m2 27.5 (3.1) 28.7 (4.5) 
Waist Circumference, cm 95.7 (10.4) 99.3 (11.1) 
Systolic Blood Pressure, mm Hg 132 (15) 132 (17) 
Diastolic Blood Pressure, mm Hg 87 (11) 87 (11) 
TC/HDL Cholesterol  4.20 (0.92) 3.92 (1.11) 
QRisk, % 5.3 (2.7) 14.2 (6.4) 
QDiabetes, % 5.5 (3.2) 12.7 (9.1) 
Low Risk, N (% sample) 81 (80) 13 (6) 
Moderate Risk, N (% sample) 20 (20) 129 (63) 
High Risk, N (% sample) 0 (0) 62 (30) 
PAL, TEE/RMR 1.74 (0.20) 1.77 (0.25) 
< 3 METs, minutes/wk 9228 (386) 8990 (571) 
> 3 METs, minutes/wk 852 (386) 1090 (571) 
> 6 METs, minutes/wk 65 (83) 109 (148) 
On body time, % 96 (3) 99 (1) 
TC: Total Cholesterol, PAL: Physical Activity Level, TEE: Total Energy Expenditure, RMR: 
Resting Metabolic Rate. 
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Moderate-to-vigorous intensity physical activity (comparison 1 and 2) 
Total weekly moderate-to-vigorous intensity physical activity was 852 ± 386 minutes for 
comparison 1 and 1090 ± 571 minutes for comparison 2 (Table 1). Thus, in spite of using 
different devices and different populations, the accumulated total amount of moderate-to-
vigorous intensity physical activity as a proportion of the week was broadly similar across the 
two comparisons. It is noteworthy that every person in the present study recorded more than 
150 minutes of moderate-to-vigorous intensity physical activity per week. The full dataset is 
available in the supplementary section online (Additional files 1 and 2). 
The relationship between standardised physical activity energy expenditure in the form of 
PAL and the amount of time spent engaged in moderate-to-vigorous physical activity is 
shown in Figure 1. Using these regression equations, a PAL of 1.75 as advocated by 
FAO/WHO/UNU equates to 861 and 1052 minutes of moderate-to-vigorous physical activity 
for comparisons 1 and 2, respectively.  
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Figure 1 
The relationship between PAL as a standardised measure of physical activity energy 
expenditure (TEE/BMR) and time engaged in moderate-to-vigorous intensity physical activity. 
Panel A shows the research instrument used in Comparison 1 (n=101) and Panel B the 
commercial instrument used in Comparison 2 (n=204). Data was collected between 2006 
and 2014. The regression line with 95% CI are included. Inspection of residuals plots 
revealed no problems with model specification, other than one substantial outlier in 
comparison 2, with a negative standardised residual >4 standard deviations from the mean. 
A sensitivity analysis revealed that removal of this case made no material difference to the 
findings, so we elected to retain it in the analyses.    
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Moderate-to-vigorous intensity physical activity (merged across both comparisons) 
We merged the data for both comparisons to determine the relationship between 
standardised physical activity energy expenditure in the form of PAL and the amount of time 
engaged in moderate-to-vigorous intensity physical activity (Figure 2; n=305). A 
comprehensive assessment of energy expenditure in the UK calculated median PAL to be 
1.63 and this is used as the basis for current UK energy requirements 26. Based on our 
analysis shown in Figure 2, we estimate that an increase from the UK median PAL of 1.63 to 
a PAL of 1.75 as advocated by FAOWHO/UNU would require an increase in moderate-to-
vigorous physical activity of 4% of waking time assuming a 16 h waking day (i.e., from 11% 
to 15% of total waking time). For someone at the UK median PAL, this would require an 
increase in moderate-to-vigorous intensity physical activity of around 255 minutes per week 
on top of existing physical activity.  
To put this into context given our focus on self-monitoring using wearable devices, we 
estimate that the total amount of moderate-to-vigorous intensity activity required to achieve a 
PAL of 1.75 is 990 minutes per week based on our merged analysis across both 
comparisons (95% confidence interval for the predicted mean, 969 to 1012 minutes). 
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Figure 2 
The relationship between PAL and time engaged in moderate-to-vigorous intensity physical 
activity merged across both comparisons (n=305). Data was collected between 2006 and 
2014. The UK median PAL is displayed (1.63) in addition to the FAO/WHO/UN 
recommended PAL of 1.75. The light grey and dark grey shaded areas depict ranges for 
moderately active and vigorously active lifestyles as set out by FAO/WHO/UN 24. 
The standard error of the estimate in predicting PAL from minutes per week of moderate to 
vigorous physical activity was 0.08 units. The amount of moderate-to-vigorous intensity 
activity associated with a lower limit of the 90% individual prediction interval for a PAL of 1.75 
was 1330 minutes per week: point estimate for PAL = 1.89 (90% individual prediction interval 
1.75 to 2.03). Thus, for a 95% probability that an individuals true PAL is ³1.75 requires an 
accumulated total of 1330 minutes of moderate-to-vigorous physical activity per week.  
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DISCUSSION 
Our results demonstrate that data from accurate physical activity monitoring produces a 
picture that is incompatible with the 150 minute per week target disseminated via national 
public-facing websites 27. Instead, when using such devices, a more appropriate target is 
~1000 minutes of moderate-to-vigorous intensity physical activity per week.  
In this study, we show that average moderate-to-vigorous intensity physical activity from 
sophisticated self-monitoring is 5 to 7-fold greater than the 150-minute per week target 
advocated by key healthcare agencies 27-29. This finding is robust and consistent across two 
different populations and using two different devices. The reason for this mismatch is 
because the 150-minute target was originally proposed to be on top of baseline physical 
activity, which is defined as normal lifestyle activities 30 31. As previously discussed by Powell 
et al., this concept has been rather soft and poorly characterised in the past because of the 
limited evidence that was available at the time 30. Perhaps as a result of this uncertainty, the 
reference to on top of baseline is usually omitted from wider dissemination aimed at the 
public 27-29. This means that the perceived target for weekly physical activity has become 150 
minutes, which is reasonable until people start using sophisticated instruments that capture 
ALL their physical activity (i.e., including baseline normal moderate-to-vigorous lifestyle 
activities). Our analysis anchors the output from sophisticated technologies to thresholds 
from the FAO/WHO/UN 24 32, and will help avoid confusion by the public and healthcare 
professionals.   
The median PAL in the UK is 1.63 26 and this is not hugely different to the median PAL 
across both comparisons reported in the present study (1.72). Thus, these observations are 
not because we have somehow recruited an unrepresentative sample. In this context, it is 
noteworthy that recent large observational studies in hundreds of participants from across 
Europe and North America demonstrate that weekly moderate-to-vigorous intensity physical 
activity is 600-1200 minutes when assessed using sophisticated research instruments 5 6 17 33-
35. It is particularly noteworthy that every person in the present study, even those with a very 
low PAL (e.g., <1.39), exceeded 150 minutes of accumulated moderate-to-vigorous intensity 
physical activity per week. This mismatch is important because most commercially available 
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devices report the sum of accumulated moderate-to-vigorous intensity physical activity as the 
primary feedback. Thus, self-monitoring with sophisticated physical activity monitors will not 
provide a picture that is compatible with current physical activity recommendations. 
We have previously proposed that the output from technological innovation in physical 
activity monitoring will require recalibration if viewed in the context of physical activity 
recommendations 5 6. Our current analysis goes some way towards achieving this goal. We 
show that, for someone at the UK median PAL, moderate-to-vigorous intensity activity will be 
around 735 minutes per week (equivalent to ~11% of waking time, assuming 8 hours of 
sleep). This approximates typical baseline moderate-to-vigorous intensity activity; and a 4% 
increase in waking moderate-to-vigorous intensity activity would be required to shift PAL to 
the level recommended by the FAO/WHO/UN (Figure 2). Our derived relationship is entirely 
consistent with an independent analysis from the Institute of Medicine (IOM) 36. The IOM 
estimated that to increase PAL from their defined sedentary level of 1.39 to their low active 
category of 1.60 would require an increase in daily moderate-to-vigorous intensity physical 
activity of 60 minutes per day. Our estimate, based on the relationship shown in Figure 2, 
would require a remarkably similar increase of 64 minutes per day (i.e., to increase PAL from 
1.39 to 1.60). Thus, after factoring in normal baseline lifestyle activities, it appears that 
approximately 1000 minutes of moderate-to-vigorous intensity physical activity per week 
corresponds to standardised guidance from the FAO/WHO/UN 24 32. This may initially seem 
like a large amount of activity, but it only represents ~15% of weekly waking time (with the 
remaining 85% distributed across sedentary and light intensity activities). This does not 
mean that people need to start doing 1000 minutes of new moderate-to-vigorous intensity 
activity  instead, it represents the sum of all activities after accounting for normal moderate-
to-vigorous lifestyle activities. 
Our results indicate that whilst 150 minutes of activity a week is a useful way to convey the 
change required at population level because it is inevitably a prescription above baseline 
normal moderate-to-vigorous lifestyle activities, this target will not tally with the picture an 
individual receives from self-monitoring because this approach inevitably captures these 
normal moderate-to-vigorous lifestyle activities. Thus, if a patient or healthcare practitioner 
uses information from self-monitoring and consults widely disseminated physical activity 
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guidance then they will form an erroneous view of their physical activity status (i.e., they are 
likely to erroneously conclude that their activity is several fold higher than the guidance). 
Future iterations of physical activity guidelines should either reflect all physical activity (i.e., 
including normal lifestyle activities) or there should be separate guidance for use in 
conjunction with sophisticated wearable physical activity monitors.   
Physical activity guidelines sometimes refer to sustained participation in moderate-to-
vigorous intensity physical activity undertaken in bouts of 10 minutes or more 7. This is often 
lost in wider dissemination where there is no reference to bouts (e.g., 27). The concept of a 
10-minute period for physical activity accumulation is largely arbitrary 6 37 and bouts of less 
than 10 minutes are demonstrably very positive for various health outcomes 38 39. It is 
therefore unsurprising that most technology companies have chosen not to build bouts into 
their platforms. Whilst bouts have low relevance to the current analysis because few 
commercial self-monitoring devices provide this feedback, readers can find an analysis of 
these data in the supplementary section online (Additional File 3).  
Our findings will apply to devices and technologies with a similar accuracy and precision to 
the instruments that were used in the present study. The multi-sensor devices that we used 
have excellent validity when compared to doubly-labeled water and/or to criterion measures 
of energy expenditure in the laboratory 11-1415-20. The quality of the output from these devices 
is quite different to simple accelerometry. This is an important consideration given the rate of 
technological development  particularly amongst the commercial sector. This is a very 
rapidly evolving field with tens of millions of devices being sold to consumers and huge 
investment from global businesses. These commercial instruments are becoming more-and-
more sophisticated and include integrated heart rate monitors, gyrometers, heat and galvanic 
skin sensors (etc.) in order to improve the accuracy of estimated energy expenditure. It is 
noteworthy that the multi-sensor instrument from Bodymedia that we used is already 
classified by the US Food and Drug Administration (FDA) as a Class II medical device. There 
was a modest difference between estimates of time engaged in at least moderate intensity 
activity between comparisons 1 and 2 (~13% and 16% of an estimated waking week, 
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respectively). To explore this issue, we examined the effect of age on the differences in the 
estimates between devices, via an age*device interaction term. A 10-year increment in age 
decreased the difference in the estimates between devices by 72 minutes (95% CI, 5 to 139 
minutes). We regard this as a trivial interaction effect in the face of a mean (SD) for 
moderate-to-vigorous intensity physical activity overall of 1011 (529) minutes. No other study 
characteristic, including wear time, substantially influenced the difference between estimates. 
It appears therefore that the small difference in the estimates might be due to device-specific 
measurement differences. Importantly, the overall conclusions from the current study are 
strengthened by the finding that two different multi-sensor devices that capture energy 
expenditure in distinctive ways and are worn in different body locations produced similar 
overall estimates of moderate-to-vigorous intensity physical activity.  
There will inevitably be some specific considerations that could affect any comparison with 
the current analysis, such as the threshold used for moderate intensity physical activity. We 
have used an absolute threshold of 3 METs since this includes most forms of walking 40 and 
is ubiquitous amongst most physical activity guidelines 6. Whilst it would be theoretically 
possible to shift this MET threshold upwards to reduce the amount of reported activity to a 
level closer to 150 minutes a week, it would be inappropriate to meddle with what is meant 
by moderate intensity physical activity to try and force a fit with existing recommendations. 
We should also highlight that these findings will also only apply when the wear time is as 
high as reported in the present study, in contrast to surveys that often report a minimum wear 
time for a valid day of only 10 hours 41 42. Wear time in most research studies is rarely as high 
as reported here but we believe that this will become more commonplace as devices become 
more comfortable to wear or are body mounted. A further consideration is that we have 
focussed on one single physical activity outcome (moderate-to-vigorous intensity activity), 
but other dimensions are also demonstrably important 3. Future recommendations should 
take into account the other physical activity dimensions to provide a more complete and 
holistic view of an individuals physical activity since we do not all have to do the same thing 
to obtain the health benefits of physical activity 3. However, for the key issue of feedback on 
moderate-to-vigorous intensity physical activity, which is likely to feature in future 
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recommendations as well as information from self-monitoring, our analysis helps interpret the 
output from wearable devices. 
Conclusions 
The emergence of affordable wearable technologies to enable the self-monitoring of physical 
activity has created many exciting opportunities. However, without adjustment, feedback 
from accurate physical activity monitors is not compatible with widely disseminated physical 
activity guidance (i.e., the recommendation to accumulate 150 minutes per week of 
moderate-to-vigorous intensity activity). After taking into account normal moderate-to-
vigorous lifestyle activities, an appropriate weekly target is approximately 1000 minutes of 
moderate-to-vigorous intensity (equivalent to ~15% of weekly waking time).  
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COMPARISON 1
Count Sex Age Height Weight BMI QRisk QDiabetes RMR TEE AEE DIT PAL On-body time <3 METs >3 METs >6 METs >3 METs >6 METs
M/F y m kg kg/m2 % % kcal/day kcal/day kcal/day kcal/day ratio % mins/week mins/week mins/week mins/week mins/week
1 M 48 1.80 88.0 27.3 3.7 4.0 1870 3445 1231 344 1.84 92 9144 936 9 275 0
2 M 54 1.93 104.7 28.0 5.7 6.6 2070 3645 1210 365 1.76 90 9008 1072 7 269 0
3 M 62 1.78 95.1 29.9 11.2 11.1 1722 2774 775 277 1.61 91 9643 437 24 76 10
4 M 55 1.81 101.2 30.9 7.4 10.6 2033 3275 914 328 1.61 95 9644 436 0 142 0
5 M 55 1.83 78.6 23.4 5.9 2.7 1789 2921 839 292 1.63 94 9294 786 63 202 0
6 M 57 1.87 96.7 27.7 7.4 6.8 1670 2677 739 268 1.60 98 9527 553 37 132 0
7 M 57 1.76 76.3 24.7 7.6 3.6 1755 3199 1124 320 1.82 90 9128 952 10 433 0
8 M 47 1.83 97.6 29.3 4.2 5.6 2007 4097 1680 410 2.04 91 8650 1430 20 240 0
9 M 45 1.77 91.8 29.2 3.0 5.0 1925 3657 1366 366 1.90 91 8995 1085 45 355 44
10 M 54 1.78 85.1 27.0 5.2 5.1 1858 3652 1428 365 1.97 91 8961 1119 10 468 0
11 M 51 1.77 90.5 28.8 4.7 6.3 1938 3622 1321 362 1.87 96 9113 967 43 333 0
12 M 54 1.81 87.8 26.9 6.1 5.1 1903 3464 1215 346 1.82 94 9135 945 13 135 0
13 M 46 1.81 107.1 32.7 3.3 9.3 2132 4283 1723 428 2.01 95 8855 1225 37 285 14
14 M 56 1.79 92.8 29.1 6.2 8.2 1934 2905 680 291 1.50 92 9742 338 18 90 15
15 M 60 1.74 78.2 25.8 10.2 5.1 1786 2669 616 267 1.49 96 9234 846 11 168 0
16 M 54 1.87 100.5 28.8 5.5 7.4 2037 3993 1557 399 1.96 97 8670 1410 7 401 0
17 M 58 1.80 89.5 27.6 8.0 7.0 1909 3297 1058 330 1.73 98 9650 430 6 78 0
18 M 53 1.80 87.4 27.0 4.2 4.9 1871 2845 1171 284 1.52 94 9531 549 18 140 0
19 M 50 1.90 85.5 23.8 3.8 2.1 1881 2755 599 276 1.46 92 9741 339 21 49 0
20 M 47 1.76 86.0 27.6 4.2 4.2 1847 2780 655 278 1.51 91 9835 245 7 0 0
21 M 58 1.78 94.3 29.9 7.6 9.7 1953 3318 1033 332 1.70 92 9239 841 33 200 0
22 M 62 1.83 89.6 26.8 11.1 6.6 1643 2661 695 266 1.62 91 9409 671 5 124 0
23 M 52 1.75 91.1 29.7 7.8 7.9 1894 3500 1256 350 1.85 98 9211 869 321 408 260
24 M 52 1.86 112.1 32.4 5.2 11.8 2157 3508 1000 351 1.63 95 9512 568 34 153 21
25 M 59 1.73 88.2 29.5 7.9 9.5 1880 3042 858 304 1.62 97 9342 738 49 346 10
26 M 53 1.75 83.9 27.3 6.1 5.5 1834 3249 1090 325 1.77 97 9114 966 47 282 0
27 M 51 1.80 108.4 33.5 6.4 12.9 2107 4094 1578 409 1.94 100 8745 1335 8 380 0
28 M 53 1.70 90.6 31.3 5.6 10.9 1923 3436 1169 344 1.79 97 9295 785 10 277 0
29 M 46 1.79 91.8 28.7 3.7 4.7 1913 3871 1571 387 2.02 95 8875 1205 3 431 0
30 M 61 1.77 71.8 22.9 10.0 3.0 1453 2530 824 253 1.74 93 9094 986 23 387 0
31 M 52 1.69 68.2 24.0 5.3 2.5 1666 2867 914 287 1.72 93 9381 699 3 130 0
32 M 49 1.77 96.6 30.8 4.8 8.4 1978 3879 1513 388 1.96 97 8638 1442 4 474 0
33 M 51 1.75 86.5 28.4 4.7 6.0 1856 3629 1410 363 1.96 94 9202 878 28 221 0
34 M 48 1.79 102.2 31.9 3.5 9.1 2037 3128 778 313 1.54 97 9594 486 10 35 0
35 M 55 1.90 88.7 24.6 5.6 3.4 1906 3403 1157 340 1.79 94 9271 809 32 239 0
36 M 61 1.73 82.4 27.5 10.8 7.1 1551 2829 994 283 1.82 93 9085 995 49 336 11
37 M 54 1.80 83.7 25.8 6.2 4.3 1834 3188 1035 319 1.74 96 9564 516 9 110 0
38 M 50 1.84 96.6 28.5 4.2 5.9 1965 3779 1436 378 1.92 92 8754 1326 71 513 50
39 M 46 1.95 129.9 34.2 3.8 11.4 2361 3823 1078 382 1.62 92 9299 781 27 274 0
40 M 47 1.64 88.6 32.9 4.2 10.4 1898 3505 1256 350 1.85 91 9097 983 15 310 0
41 M 61 1.76 90.8 29.3 8.6 10.0 1649 2264 635 226 1.37 98 9552 528 13 62 0
42 M 50 1.96 103.0 26.8 4.1 4.2 2050 3574 1167 357 1.74 97 9265 815 28 140 0
43 M 56 1.86 93.0 27.0 8.2 5.6 1956 3445 1145 345 1.76 96 9287 793 94 345 86
44 M 50 1.87 95.3 27.3 4.1 4.5 1985 3684 1330 368 1.86 99 9095 985 7 341 0
Physical activity Activity bouts
COMPARISON 1
Count Sex Age Height Weight BMI QRisk QDiabetes RMR TEE AEE DIT PAL On-body time <3 METs >3 METs >6 METs >3 METs >6 METs
M/F y m kg kg/m2 % % kcal/day kcal/day kcal/day kcal/day ratio % mins/week mins/week mins/week mins/week mins/week
Physical activity Activity bouts
45 M 45 1.82 97.3 29.4 2.7 4.9 1994 3126 820 313 1.57 95 9431 649 7 184 0
46 M 52 1.88 102.4 29.0 4.6 6.8 2052 3179 809 318 1.55 97 9332 748 14 206 0
47 M 50 1.77 71.7 23.0 4.3 1.8 1696 2696 731 270 1.59 98 9503 577 22 72 0
48 M 53 1.78 85.5 27.0 5.6 4.9 1847 3396 1211 340 1.84 97 9018 1062 6 243 0
49 M 57 1.76 72.0 23.2 10.0 2.8 1698 2608 650 261 1.54 96 9563 517 4 281 0
50 M 56 1.75 71.7 23.3 8.2 2.8 1698 3438 1396 344 2.02 98 8851 1229 10 344 0
51 M 55 1.75 77.7 25.5 7.1 4.0 1766 2891 836 289 1.64 99 9395 685 17 288 0
52 M 47 1.77 96.8 31.0 3.1 7.5 1984 3608 1263 361 1.82 96 9115 965 18 220 0
53 M 57 1.76 95.0 30.5 8.0 11.0 1961 3604 1283 360 1.84 98 8972 1108 19 342 0
54 M 55 1.74 89.6 29.6 8.4 8.9 1899 3078 871 308 1.62 97 9557 523 41 124 33
55 M 46 1.67 76.0 27.3 2.5 3.6 1743 3866 2122 387 2.22 98 8382 1698 131 835 36
56 M 45 1.89 85.0 23.8 2.0 1.6 1858 3169 1309 317 1.71 98 9145 935 192 405 33
57 M 57 1.83 77.0 23.0 5.4 2.6 1755 3002 1247 300 1.71 95 9495 585 156 395 150
58 M 57 1.77 80.0 25.5 6.6 4.5 1789 3437 1647 344 1.92 99 9221 859 231 353 187
59 M 61 1.72 63.0 21.3 7.7 2.2 1594 2647 1052 265 1.66 96 9301 779 237 404 166
60 M 47 1.82 83.0 25.1 2.3 2.4 1824 3151 1327 315 1.73 98 9310 770 214 410 161
61 M 46 1.78 78.0 24.6 1.9 2.0 1652 2931 1280 293 1.77 97 9362 718 241 323 233
62 M 49 1.79 77.5 24.2 3.7 2.3 1766 3027 3027 303 1.71 100 9507 573 245 338 239
63 M 59 1.82 89.0 26.9 9.4 6.1 1892 3023 1130 302 1.60 98 9180 900 123 277 37
64 M 56 1.79 86.0 26.8 8.1 5.5 1858 2857 999 286 1.54 96 9541 539 8 112 0
65 M 61 1.76 80.0 25.8 12.2 5.4 1523 2242 718 224 1.47 96 9721 359 2 0 0
66 M 48 1.74 104.0 34.4 5.1 12.8 2122 4038 1916 404 1.90 96 8977 1103 64 131 0
67 M 54 1.78 88.0 27.8 7.4 6.1 1973 3150 1177 315 1.60 97 9545 535 4 72 0
68 M 55 1.83 69.0 20.6 4.7 1.4 1663 3336 1673 334 2.01 99 8757 1323 86 449 19
69 M 56 1.81 87.0 26.6 7.8 5.2 1870 2973 1104 297 1.59 95 9654 426 6 92 0
70 M 59 1.80 80.0 24.7 9.4 4.0 1789 2731 941 273 1.53 97 9606 474 17 116 0
71 M 49 1.86 94.0 27.2 3.9 4.2 1950 3534 1231 353 1.81 96 9183 897 13 232 0
72 M 46 1.85 83.0 24.3 3.3 1.9 1824 2891 778 289 1.59 99 9322 758 28 636 0
73 M 54 1.80 85.0 26.2 6.5 4.5 1812 3179 1049 318 1.75 96 9135 945 32 373 10
74 M 56 1.80 101.0 31.2 8.5 11.5 2019 3410 1050 341 1.69 98 9616 464 3 24 0
75 M 59 1.76 83.0 26.8 11.0 6.8 1824 3116 981 297 1.71 97 9507 573 4 115 0
76 M 41 1.78 76.7 24.2 1.2 1.3 1716 2942 931 294 1.71 98 9425 655 130 241 106
77 M 52 1.69 80.2 28.1 5.9 5.8 1793 2459 420 246 1.37 97 9892 188 96 122 73
78 M 49 1.71 75.5 25.8 2.6 3.1 1718 3761 1666 376 2.19 96 8233 1847 176 889 54
79 M 47 1.75 78.9 25.7 2.8 2.8 1630 2889 970 289 1.77 93 9152 928 79 265 0
80 M 51 1.77 86.1 27.4 5.4 5.0 2086 3532 1093 353 1.69 96 9446 634 8 298 0
81 M 36 1.76 89.7 29.1 0.8 2.2 1924 4144 1806 414 2.15 100 8448 1632 280 786 169
82 M 48 1.90 109.1 30.2 3.5 7.0 1661 2932 978 293 1.77 99 9179 901 117 180 80
83 M 52 1.86 107.9 31.1 4.8 10.0 1845 2744 625 274 1.49 98 9466 614 22 299 0
84 M 49 1.82 99.6 30.2 3.6 7.4 1809 2742 658 274 1.52 96 9604 476 79 190 48
85 M 50 1.65 98.0 35.8 5.8 16.5 1997 3311 983 331 1.66 98 9399 681 126 253 105
86 M 38 1.79 75.0 23.5 0.7 0.8 1793 3367 1237 337 1.88 99 8999 1081 153 456 27
87 M 43 1.72 68.1 22.9 1.4 1.1 1499 3720 1849 372 2.48 98 7600 2480 303 1296 185
88 M 35 1.73 71.7 23.8 0.4 0.7 2082 3441 1015 344 1.65 96 9479 601 84 204 35
COMPARISON 1
Count Sex Age Height Weight BMI QRisk QDiabetes RMR TEE AEE DIT PAL On-body time <3 METs >3 METs >6 METs >3 METs >6 METs
M/F y m kg kg/m2 % % kcal/day kcal/day kcal/day kcal/day ratio % mins/week mins/week mins/week mins/week mins/week
Physical activity Activity bouts
89 M 50 1.86 85.0 24.7 5.0 2.6 1692 2845 869 285 1.68 95 9388 692 121 419 119
90 M 48 1.78 81.9 25.8 3.3 3.0 1654 2984 1032 298 1.80 97 9051 1029 118 494 54
91 M 47 1.87 76.0 21.9 2.1 1.2 1496 2571 818 257 1.72 95 9263 817 84 266 56
92 M 47 1.76 78.6 25.5 3.2 2.8 1554 2590 777 259 1.67 97 9332 748 155 340 89
93 M 54 1.72 73.6 24.9 4.3 3.5 1496 2513 766 251 1.68 98 9358 722 84 158 76
94 M 45 1.80 89.9 27.7 2.7 3.7 1606 2703 827 270 1.68 96 9015 1065 0 248 0
95 M 51 1.76 81.5 26.4 4.0 4.1 1573 2629 793 263 1.67 93 9337 743 274 384 168
96 M 35 1.78 111.6 35.2 1.2 6.2 2282 3800 1138 380 1.67 96 9282 798 41 103 14
97 M 41 1.84 97.5 28.9 1.7 3.2 2039 3517 1126 352 1.72 97 9211 869 62 331 23
98 M 44 1.95 114.0 29.9 2.8 5.3 2108 2902 503 290 1.38 93 9830 250 1 38 0
99 M 55 1.90 92.0 25.5 5.5 4.1 1704 2836 848 284 1.66 95 9414 666 73 183 18
100 M 44 1.73 81.5 27.2 4.0 3.0 1781 3203 1102 320 1.80 96 8880 1200 18 323 0
101 M 37 1.73 93.2 31.1 0.9 3.7 1859 4660 2335 466 2.51 99 7766 2314 370 1082 155
Mean 51 1.79 88.4 27.5 5.3 5.5 1846 3220 1125 322 1.74 96 9228 852 65 287 34
SD 6 0.06 11.7 3.1 2.7 3.2 176 473 402 47 0.20 3 386 386 83 209 62
Min 35 1.64 63.0 20.6 0.4 0.7 1453 2242 420 224 1.37 90 7600 188 0 0 0
Max 62 1.96 129.9 35.8 12.2 16.5 2361 4660 3027 466 2.51 100 9892 2480 370 1296 260
COMPARISON 2
Count Sex Age Height Weight BMI QRisk QDiabetes RMR TEE AEE DIT PAL On-body time <3 METs >3 METs >6 METs >3 METs >6 METs
M/F y m kg kg/m2 % % kcal/day kcal/day kcal/day kcal/day ratio % mins/week mins/week mins/week mins/week mins/week
1 M 68 1.76 96.4 31.1 18.1 22.6 1751 2790 1039 279 1.59 98 9394 686 56 413 10
2 M 67 1.63 73.2 27.7 17.0 9.3 1409 2838 1428 284 2.01 98 8040 2040 151 1733 55
3 M 43 1.74 108.8 35.9 3.6 10.0 2119 3572 1453 357 1.69 99 9094 986 3 620 0
4 F 61 1.63 99.0 37.3 8.3 15.2 1544 2758 1214 276 1.79 95 8945 1135 17 611 0
5 M 58 1.77 89.6 28.6 14.0 10.1 1899 3046 1147 305 1.60 99 9434 646 9 283 0
6 F 71 1.66 82.5 29.9 14.9 26.4 1428 2337 909 234 1.64 99 9225 855 32 562 0
7 F 51 1.62 88.5 33.7 8.2 24.7 1564 2428 864 243 1.55 100 9329 751 75 501 40
8 F 66 1.71 70.5 24.3 9.2 4.2 1354 2022 668 202 1.49 96 9723 357 4 178 0
9 F 69 1.59 81.5 32.2 11.6 23.6 1388 2237 849 224 1.61 99 9638 442 19 159 0
10 M 59 1.82 96.6 29.2 13.2 16.3 1979 3392 1413 339 1.71 99 9034 1046 142 826 70
11 M 63 1.74 74.0 24.6 12.2 4.6 1524 2838 1314 284 1.86 97 8561 1519 147 1100 21
12 M 66 1.82 87.4 26.4 14.6 6.7 1728 3899 2171 390 2.26 99 7968 2112 404 1614 30
13 M 65 1.71 69.9 23.9 14.6 4.1 1462 3018 1556 302 2.06 99 8292 1788 319 1425 121
14 M 69 1.73 91.2 30.6 19.8 27.8 1670 3151 1481 315 1.89 100 8369 1711 66 1376 0
15 F 58 1.66 102.1 37.1 5.5 15.3 1675 2787 1112 279 1.66 99 9277 803 11 308 0
16 M 68 1.76 78.5 25.3 23.9 6.2 1589 2195 607 220 1.38 99 9756 324 2 176 0
17 F 58 1.65 97.5 36.0 6.1 22.8 1637 2204 567 220 1.35 97 9774 306 1 152 0
18 F 56 1.59 84.0 33.1 3.5 16.2 1528 2465 937 246 1.61 98 9178 902 34 504 0
19 F 67 1.71 70.0 24.1 11.1 8.1 1350 2014 664 201 1.49 100 9660 420 7 231 0
20 F 58 1.66 86.0 31.4 6.6 15.5 1544 2557 1013 256 1.66 96 9333 747 15 363 0
21 F 64 1.70 123.7 43.1 7.5 34.0 1769 2733 964 273 1.54 99 9790 290 0 82 0
22 M 66 1.76 70.5 22.8 10.5 3.0 1516 2511 994 251 1.66 99 9247 833 56 515 11
23 M 71 1.78 82.7 26.1 27.0 13.0 1646 3328 1682 333 2.02 100 8478 1602 220 1194 15
24 M 62 1.72 70.9 24.0 9.7 3.5 1481 2207 726 221 1.49 100 9650 430 74 200 24
25 M 67 1.66 66.3 24.1 16.3 7.6 1381 3227 1846 323 2.34 99 7673 2407 500 1784 163
26 M 64 1.84 84.8 25.2 11.2 4.5 1719 2959 1240 296 1.72 99 9198 882 72 630 0
27 M 67 1.80 89.4 27.6 13.3 14.5 1727 2782 1055 278 1.61 99 9409 671 28 302 0
28 F 67 1.67 67.3 24.3 8.8 3.2 1310 2507 1197 251 1.91 99 8493 1587 105 1140 13
29 M 63 1.77 81.1 26.0 10.2 11.3 1617 2965 1348 297 1.83 99 8792 1288 99 870 0
30 F 62 1.67 74.0 26.5 7.9 7.5 1366 2168 802 217 1.59 98 9429 651 34 425 0
31 M 68 1.68 69.4 24.7 14.3 5.6 1424 2785 1362 279 1.96 97 8381 1699 175 1304 22
32 M 69 1.69 75.4 26.6 24.8 10.1 1488 3268 1781 327 2.20 99 8203 1877 263 1237 99
33 F 70 1.63 93.0 35.0 14.4 23.9 1497 2233 736 223 1.49 100 9702 378 19 124 0
34 M 60 1.98 112.8 28.8 14.0 7.5 2165 3829 1664 383 1.77 100 9038 1042 18 562 0
35 M 52 1.93 101.7 27.3 17.4 4.6 2037 3404 1367 340 1.67 100 9251 829 39 546 19
36 M 64 1.73 61.6 20.6 15.9 6.2 1406 2141 735 214 1.52 99 9592 488 124 316 60
37 M 69 1.78 82.0 25.9 16.6 6.5 1640 3336 1696 334 2.03 100 8513 1567 199 1255 99
38 M 62 1.76 107.3 34.8 12.4 18.2 1845 3110 1264 311 1.69 100 9054 1026 37 671 0
39 M 57 1.73 92.5 30.9 6.7 22.6 1932 3690 1758 369 1.91 98 8438 1642 60 1138 30
40 M 64 1.79 71.5 22.3 10.7 4.2 1554 3825 2271 383 2.46 98 7622 2458 808 1884 325
41 F 71 1.58 64.4 26.0 9.3 3.9 1246 3053 1807 305 2.45 99 7578 2502 638 1928 0
42 M 62 1.73 88.1 29.4 11.8 9.2 1647 3144 1497 314 1.91 99 8562 1518 21 945 0
43 F 71 1.57 73.8 30.1 14.0 18.5 1317 2059 743 206 1.56 100 9466 614 30 328 0
44 M 66 1.71 113.0 38.6 16.0 41.6 1853 3417 1564 342 1.84 99 8506 1574 2 802 0
Physical activity Activity bouts
COMPARISON 2
Count Sex Age Height Weight BMI QRisk QDiabetes RMR TEE AEE DIT PAL On-body time <3 METs >3 METs >6 METs >3 METs >6 METs
M/F y m kg kg/m2 % % kcal/day kcal/day kcal/day kcal/day ratio % mins/week mins/week mins/week mins/week mins/week
Physical activity Activity bouts
45 M 61 1.72 81.9 27.7 15.4 12.3 1581 2341 761 234 1.48 99 9466 614 87 413 0
46 M 70 1.78 92.2 29.1 18.8 17.5 1733 3504 1771 350 2.02 100 8292 1788 269 1556 120
47 F 66 1.66 83.0 30.1 8.7 10.2 1432 2524 1092 252 1.76 99 9232 848 6 397 0
48 F 64 1.56 80.4 33.0 10.4 16.3 1366 2233 867 223 1.63 99 9408 672 22 364 0
49 F 70 1.62 56.3 21.4 10.3 2.2 1205 2228 1023 223 1.85 100 9084 996 405 644 234
50 M 44 1.85 119.4 34.9 10.3 12.8 2241 5014 2773 501 2.24 99 7488 2592 28 2041 23
51 M 65 1.78 86.0 27.3 13.5 8.3 1671 2813 1141 281 1.68 98 9159 921 66 538 0
52 M 67 1.68 68.0 24.1 15.8 4.5 1416 3236 1821 324 2.29 99 8037 2043 575 1570 312
53 M 68 1.76 89.6 28.9 15.1 20.1 1689 3246 1556 325 1.92 99 8475 1605 21 1229 0
54 M 70 1.82 74.8 22.7 13.5 6.7 1609 3004 1395 300 1.87 99 9054 1026 119 715 10
55 M 59 1.74 65.6 21.6 7.2 2.5 1624 3643 2019 364 2.24 100 8261 1819 573 1455 226
56 M 64 1.81 89.0 27.3 24.8 17.2 1730 3105 1375 310 1.79 98 9053 1027 42 640 26
57 M 70 1.69 80.1 28.2 25.7 9.6 1530 2690 1160 269 1.76 97 8997 1083 132 737 26
58 M 57 1.80 95.5 29.5 17.2 13.1 1967 3479 1512 348 1.77 98 9062 1018 14 521 0
59 M 61 1.82 99.3 30.0 14.9 11.1 1836 4130 2295 413 2.25 100 8136 1944 82 1120 0
60 M 54 1.73 94.1 31.4 14.3 24.5 1951 3151 1200 315 1.62 98 9370 710 44 413 0
61 M 69 1.78 91.3 28.8 16.9 10.1 1724 3735 2011 374 2.17 98 8012 2068 194 1465 50
62 M 67 1.81 102.7 31.3 29.6 20.6 1857 2879 1022 288 1.55 99 9388 692 19 361 0
63 F 70 1.58 84.6 33.9 14.2 14.8 1408 2306 898 231 1.64 99 9606 474 28 237 0
64 F 68 1.65 76.5 28.1 13.2 11.3 1376 2153 777 215 1.56 99 9534 546 35 303 0
65 M 69 1.74 86.7 28.6 17.8 9.5 1644 2801 1157 280 1.70 100 9015 1065 115 844 0
66 M 63 1.84 84.3 24.8 11.9 3.9 1723 2831 1108 283 1.64 100 9235 845 10 699 0
67 F 69 1.61 54.6 21.0 12.4 2.6 1186 2382 1197 238 2.01 98 8520 1560 419 1198 217
68 F 70 1.64 89.3 33.4 12.3 18.6 1470 2741 1271 274 1.86 99 9161 919 10 372 0
69 F 60 1.68 60.9 21.5 8.2 1.8 1269 2346 1077 235 1.85 99 9136 944 220 510 60
70 M 70 1.73 81.3 27.2 20.5 10.8 1585 2739 1154 274 1.73 96 9271 809 22 411 0
71 M 66 1.77 74.1 23.8 11.9 4.2 1554 2781 1227 278 1.79 99 8976 1104 82 798 30
72 M 64 1.82 91.0 27.5 13.4 7.8 1760 2848 1088 285 1.62 98 9056 1024 42 633 0
73 M 64 1.78 97.2 30.7 9.7 10.9 1778 3259 1481 326 1.83 99 8719 1361 10 836 0
74 M 59 1.75 85.7 28.1 12.5 13.1 1854 4010 2155 401 2.16 99 8170 1910 285 1303 151
75 M 60 1.71 79.6 27.2 9.0 6.5 1492 3424 1932 342 2.30 99 7533 2547 170 1706 63
76 M 58 1.75 103.0 33.6 14.8 16.8 2053 3929 1876 393 1.91 99 8450 1630 87 1156 78
77 M 66 1.69 87.5 30.8 21.0 14.9 1598 2411 813 241 1.51 100 9559 521 12 245 0
78 M 63 1.80 85.5 26.4 11.8 6.3 1691 2588 897 259 1.53 97 9505 575 23 408 0
79 M 65 1.65 75.6 27.8 20.5 10.1 1455 3115 1660 312 2.14 98 7860 2220 242 1763 32
80 M 65 1.83 83.5 25.1 10.2 5.3 1697 2546 848 255 1.50 99 9826 254 70 92 69
81 F 71 1.69 76.4 26.8 12.4 5.4 1502 2726 1224 273 1.82 99 8649 1431 67 1016 0
82 M 52 1.72 93.8 31.7 24.3 15.6 1947 4058 2111 406 2.08 99 7937 2143 71 1712 0
83 M 66 1.70 71.5 24.7 16.3 11.2 1467 2966 1499 297 2.02 98 8351 1729 208 1267 45
84 M 65 1.63 65.2 24.5 29.6 7.5 1342 2960 1618 296 2.21 99 7990 2090 618 1818 329
85 M 62 1.70 73.2 25.5 7.8 4.8 1482 3102 1620 310 2.09 99 8405 1675 585 1315 542
86 M 69 1.82 96.6 29.2 20.9 10.9 1811 3064 1252 306 1.69 97 9138 942 7 501 0
87 F 71 1.57 61.0 24.9 15.3 7.0 1217 2317 1099 232 1.90 98 8990 1090 302 592 82
88 M 67 1.82 86.2 25.9 23.8 10.1 1717 3879 2163 388 2.26 99 7867 2213 308 1788 42
COMPARISON 2
Count Sex Age Height Weight BMI QRisk QDiabetes RMR TEE AEE DIT PAL On-body time <3 METs >3 METs >6 METs >3 METs >6 METs
M/F y m kg kg/m2 % % kcal/day kcal/day kcal/day kcal/day ratio % mins/week mins/week mins/week mins/week mins/week
Physical activity Activity bouts
89 F 65 1.61 72.1 28.0 7.0 5.7 1323 2196 873 220 1.66 98 9403 677 17 376 0
90 M 62 1.56 87.8 36.1 33.2 76.1 1479 2864 1385 286 1.94 100 8810 1270 157 991 0
91 F 69 1.58 53.8 21.5 11.3 7.5 1165 1827 661 183 1.57 99 9291 789 47 428 11
92 M 68 1.75 81.3 26.5 23.7 7.6 1604 2785 1181 279 1.74 98 9211 869 15 460 0
93 M 65 1.76 106.5 34.6 11.6 19.2 1843 3655 1813 366 1.98 99 8197 1883 63 1310 16
94 M 69 1.79 92.8 29.0 29.5 31.2 1748 3066 1318 307 1.75 99 8867 1213 7 818 0
95 F 66 1.52 63.7 27.8 9.2 9.6 1216 2449 1233 245 2.01 100 8493 1587 329 1032 143
96 F 52 1.63 110.9 41.7 3.8 20.9 1746 2642 896 264 1.51 98 9458 622 1 193 0
97 F 62 1.61 69.8 26.9 1305 2826 1521 283 2.17 99 8378 1702 618 1366 448
98 M 68 1.65 92.8 34.1 19.2 24.9 1612 2179 567 218 1.35 99 9710 370 3 144 0
99 M 68 1.65 55.9 20.5 24.0 6.1 1277 2100 824 210 1.65 96 9174 906 128 494 52
100 M 68 1.85 96.9 28.3 13.9 7.7 1843 2813 969 281 1.53 100 9491 589 29 423 0
101 M 68 1.86 108.2 31.4 20.7 15.7 1955 3210 1255 321 1.64 98 9581 499 0 165 0
102 F 69 1.63 66.3 25.0 10.6 12.1 1287 2024 737 202 1.57 99 9524 556 104 307 52
103 M 70 1.80 107.7 33.2 24.4 28.9 1893 3509 1617 351 1.85 99 8758 1322 57 923 0
104 F 71 1.53 53.5 22.9 10.6 6.2 1140 1678 538 168 1.47 98 9826 254 44 145 20
105 F 60 1.65 92.3 34.1 4.1 21.1 1595 2818 1223 282 1.77 99 8970 1110 19 625 0
106 M 65 1.74 77.9 25.7 11.8 6.2 1564 3674 2110 367 2.35 99 7631 2449 497 1943 151
107 F 71 1.64 66.4 24.8 11.9 4.3 1292 2658 1367 266 2.06 99 8440 1640 416 1159 190
108 M 69 1.77 74.4 23.9 15.6 7.8 1561 2696 1135 270 1.73 99 8942 1138 38 632 0
109 M 62 1.74 78.4 26.0 11.4 6.4 1568 3049 1480 305 1.94 99 8721 1359 163 960 27
110 M 58 1.80 102.0 31.7 8.0 11.7 2041 5023 2982 502 2.46 100 7140 2940 30 2390 0
111 F 56 1.64 80.2 30.0 11.9 16.9 1497 2325 828 232 1.55 99 9386 694 15 323 0
112 F 67 1.68 91.1 32.5 16.1 17.5 1505 2647 1142 265 1.76 99 9322 758 36 400 21
113 F 69 1.68 95.8 34.1 12.6 13.1 1542 2713 1172 271 1.76 100 9081 999 1 442 0
114 F 51 1.78 125.5 39.8 2.5 11.5 1865 3173 1308 317 1.70 99 9414 666 0 211 0
115 M 67 1.77 84.0 27.0 11.9 15.0 1648 2901 1253 290 1.76 98 8876 1204 57 791 0
116 M 70 1.76 84.9 27.4 32.6 13.9 1647 3118 1471 312 1.89 99 8713 1367 128 905 14
117 F 68 1.56 74.1 30.4 9.8 8.5 1316 2580 1264 258 1.96 100 8460 1621 169 948 0
118 M 64 1.78 86.2 27.2 11.7 7.0 1678 2978 1299 298 1.77 99 8922 1158 36 751 0
119 M 71 1.75 85.8 28.0 19.9 10.4 1645 2639 993 264 1.60 97 9493 587 21 212 0
120 F 67 1.66 54.1 19.6 20.5 1.9 1204 2036 831 204 1.69 100 9187 893 154 506 82
121 F 70 1.75 89.3 29.2 13.8 6.4 1523 2440 917 244 1.60 98 9439 641 7 290 0
122 M 57 1.87 108.6 31.1 9.5 10.7 2117 3380 1263 338 1.60 98 9479 601 0 257 0
123 M 66 1.82 96.6 29.2 32.6 13.0 1811 3059 1248 306 1.69 98 9280 800 50 548 18
124 M 70 1.72 90.4 30.6 31.6 19.6 1658 2846 1188 285 1.72 99 9161 919 46 520 0
125 F 61 1.54 82.2 34.6 8.2 27.7 1371 2009 639 201 1.47 98 9514 566 0 257 0
126 M 56 1.87 120.0 34.5 8.1 17.1 2247 4048 1800 405 1.80 99 8835 1245 0 786 0
127 M 62 1.79 94.2 29.6 22.0 10.9 1760 3173 1413 317 1.80 99 8727 1353 52 913 0
128 M 63 1.65 76.2 28.0 11.5 7.0 1461 2283 822 228 1.56 96 9278 802 49 578 0
129 M 66 1.83 91.8 27.4 15.4 11.7 1777 3073 1295 307 1.73 99 9183 897 8 500 0
130 F 65 1.56 79.6 32.7 10.2 10.9 1359 2312 953 231 1.70 99 9114 966 59 562 0
131 M 57 1.81 82.9 25.3 11.4 5.4 1822 3541 1719 354 1.94 99 8658 1422 176 752 0
132 F 67 1.54 84.0 35.7 11.3 17.3 1385 2108 723 211 1.52 99 9770 310 5 78 0
COMPARISON 2
Count Sex Age Height Weight BMI QRisk QDiabetes RMR TEE AEE DIT PAL On-body time <3 METs >3 METs >6 METs >3 METs >6 METs
M/F y m kg kg/m2 % % kcal/day kcal/day kcal/day kcal/day ratio % mins/week mins/week mins/week mins/week mins/week
Physical activity Activity bouts
133 M 68 1.62 81.4 31.2 25.0 14.8 1479 2387 908 239 1.61 99 9329 751 60 398 11
134 M 66 1.69 74.8 26.2 14.1 18.4 1487 2976 1489 298 2.00 100 8278 1802 190 1254 42
135 M 54 1.79 95.0 29.6 11.6 14.4 1961 3182 1221 318 1.62 99 9466 614 51 389 21
136 M 49 1.81 123.3 37.8 11.6 32.5 2285 3737 1452 374 1.64 100 9131 949 3 743 0
137 F 70 1.75 81.6 26.8 17.2 10.7 1462 2353 891 235 1.61 99 9300 780 66 535 0
138 M 48 1.81 85.4 26.1 9.5 4.2 1851 4420 2569 442 2.39 98 7212 2868 313 2563 58
139 F 66 1.65 57.0 20.9 10.4 2.3 1222 2045 823 205 1.67 99 9368 712 111 368 27
140 F 59 1.57 83.4 33.8 12.6 27.3 1523 2443 920 244 1.60 99 9273 807 86 458 22
141 F 70 1.49 58.6 26.4 14.3 5.0 1162 1876 715 188 1.62 99 9153 927 203 635 56
142 F 66 1.68 86.6 30.9 14.1 25.3 1469 2179 710 218 1.48 98 9538 542 15 366 0
143 F 58 1.53 76.9 33.1 4.1 18.6 1470 2150 680 215 1.46 99 9595 485 6 168 0
144 M 70 1.83 83.0 24.9 14.4 5.1 1698 2659 961 266 1.57 99 9526 554 117 310 70
145 M 68 1.66 75.2 27.3 18.6 11.4 1462 2210 748 221 1.51 99 9569 511 119 346 84
146 M 61 1.67 79.2 28.6 19.6 15.6 1508 2792 1284 279 1.85 98 8843 1237 51 730 13
147 M 69 1.90 117.8 32.8 19.3 21.1 2081 3575 1494 358 1.72 100 9276 804 3 425 0
148 M 68 1.73 85.8 28.7 18.6 12.9 1626 2384 758 238 1.47 98 9675 405 22 167 0
149 M 68 1.78 84.5 26.7 23.0 6.6 1662 3198 1536 320 1.92 99 8680 1400 208 951 24
150 F 69 1.53 84.0 35.7 16.1 44.7 1380 2125 745 213 1.54 99 9430 650 3 321 0
151 M 65 1.73 97.2 32.5 14.8 17.6 1729 3198 1469 320 1.85 98 8662 1418 76 1030 0
152 M 68 1.86 98.4 28.4 28.6 31.8 1867 3798 1931 380 2.03 99 8307 1773 101 1260 37
153 M 67 1.77 69.8 22.3 15.0 4.7 1519 2772 1253 277 1.82 99 8900 1180 232 810 55
154 F 67 1.55 67.4 28.2 13.2 6.8 1259 2853 1595 285 2.27 98 7992 2088 598 1514 187
155 F 43 1.67 107.7 38.8 3.4 20.2 1720 2549 829 255 1.48 99 9577 503 9 244 0
156 F 61 1.50 52.6 23.5 10.8 3.0 1119 1549 430 155 1.38 99 9782 298 21 101 0
157 M 67 1.83 97.3 29.2 17.2 9.5 1827 3389 1562 339 1.85 99 8629 1451 40 1050 0
158 F 70 1.65 62.9 23.2 12.2 2.8 1269 2430 1161 243 1.92 98 8661 1419 211 918 78
159 M 67 1.71 78.1 26.8 33.1 18.8 1537 2608 1071 261 1.70 98 9000 1080 98 879 28
160 F 63 1.64 84.3 31.3 11.4 12.1 1433 1927 494 193 1.34 98 9857 223 4 86 0
161 M 68 1.76 92.9 30.0 21.1 19.9 1719 2798 1079 280 1.63 98 9202 878 5 506 0
162 M 64 1.75 85.3 27.9 18.7 7.3 1641 2424 783 242 1.48 100 9603 477 3 208 0
163 M 61 1.86 92.9 26.8 19.9 6.8 1817 3446 1629 345 1.90 99 8984 1096 114 654 16
164 M 60 1.60 68.6 26.8 13.6 7.3 1343 3419 2076 342 2.55 96 7960 2120 473 1578 130
165 F 68 1.60 68.4 26.7 12.7 4.9 1289 2128 839 213 1.65 100 9304 776 33 478 0
166 F 45 1.73 99.2 33.2 2.3 13.8 1651 2982 1331 298 1.81 99 8611 1469 22 873 0
167 M 59 1.74 72.0 23.8 10.8 3.8 1697 2926 1228 293 1.72 99 9103 977 260 634 99
168 F 69 1.71 71.5 24.5 10.5 3.5 1364 2274 910 227 1.67 99 9442 638 59 280 0
169 F 56 1.58 93.3 37.3 5.1 25.6 1603 2349 746 235 1.47 98 9615 465 8 185 0
170 F 61 1.60 70.7 27.6 8.9 5.5 1308 2224 916 222 1.70 99 9315 765 94 350 14
171 M 64 1.79 92.3 28.7 13.1 19.3 1743 3234 1491 323 1.86 99 8685 1395 42 965 12
172 M 60 1.88 103.0 29.0 9.5 10.0 1928 3682 1755 368 1.91 99 8767 1313 20 759 0
173 M 68 1.80 89.4 27.5 13.5 8.3 1727 2935 1209 294 1.70 98 9224 856 67 496 53
174 M 48 1.77 116.2 37.1 3.6 31.1 2204 3165 961 317 1.44 100 9809 271 11 113 0
175 M 63 1.79 71.3 22.4 9.4 2.7 1553 2973 1421 297 1.92 100 8550 1530 142 1085 48
176 M 63 1.64 73.3 27.4 12.9 14.8 1420 2656 1236 266 1.87 95 8712 1369 193 819 30
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Count Sex Age Height Weight BMI QRisk QDiabetes RMR TEE AEE DIT PAL On-body time <3 METs >3 METs >6 METs >3 METs >6 METs
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Physical activity Activity bouts
177 M 64 1.71 71.6 24.6 16.4 4.5 1478 2592 1115 259 1.75 100 9079 1001 171 626 28
178 M 69 1.74 91.0 29.9 34.1 19.2 1683 2977 1294 298 1.77 98 8983 1097 18 463 11
179 M 59 1.78 75.9 24.0 11.0 3.8 1742 3187 1445 319 1.83 99 8700 1380 74 913 11
180 F 66 1.67 74.5 26.7 14.4 6.1 1370 2103 734 210 1.54 99 9665 415 84 242 0
181 F 49 1.64 97.0 36.2 1.3 17.9 1866 2979 1113 298 1.60 99 9454 626 3 265 0
182 M 67 1.76 100.4 32.5 25.4 27.1 1787 3284 1497 328 1.84 99 8762 1318 3 785 0
183 M 46 1.72 95.7 32.3 8.1 20.2 1969 3010 1041 301 1.53 100 9421 659 1 364 0
184 F 67 1.53 49.2 21.0 13.2 3.8 1106 1692 586 169 1.53 87 9539 541 67 309 0
185 M 61 1.80 111.3 34.4 12.5 22.9 1925 3268 1342 327 1.70 99 8941 1139 2 668 0
186 F 59 1.63 106.2 40.2 6.9 15.7 1708 2326 618 233 1.36 98 9694 386 0 184 0
187 M 53 1.70 73.2 25.3 9.6 8.0 1711 2641 930 264 1.54 99 9552 528 42 242 0
188 M 69 1.83 86.0 25.6 17.2 5.3 1725 2427 702 243 1.41 99 9861 219 3 79 0
189 M 70 1.79 99.0 31.1 18.5 18.7 1804 3510 1706 351 1.95 99 8625 1455 151 1079 10
190 M 69 1.73 74.9 25.1 14.8 5.2 1525 2336 811 234 1.53 99 9490 590 21 350 0
191 M 62 1.72 79.3 26.8 16.4 7.1 1557 2409 852 241 1.55 99 9593 487 53 295 25
192 M 49 1.67 89.6 32.1 6.7 23.2 1899 3420 1520 342 1.80 99 8638 1442 27 909 0
193 F 70 1.58 62.6 25.1 12.5 4.3 1235 2376 1141 238 1.92 99 8747 1333 349 873 69
194 M 62 1.73 89.0 29.6 13.3 16.3 1659 2800 1141 280 1.69 99 9043 1037 61 752 0
195 M 57 1.81 89.8 27.4 14.0 10.3 1901 3124 1222 312 1.64 100 9270 810 78 536 15
196 M 68 1.93 106.1 28.6 17.5 15.1 2000 3384 1384 338 1.69 97 9167 913 17 584 10
197 M 67 1.77 90.3 28.8 22.7 10.0 1706 3163 1458 316 1.85 99 8573 1507 114 996 99
198 M 66 1.85 88.1 25.9 16.7 5.9 1758 2961 1202 296 1.68 99 9321 759 33 352 0
199 M 59 1.68 77.6 27.5 6.9 6.5 1762 2704 943 270 1.54 94 9435 645 67 349 11
200 F 68 1.55 88.0 36.9 12.9 15.6 1421 2100 679 210 1.48 99 9507 573 7 295 0
201 F 68 1.69 66.9 23.4 11.2 5.4 1319 2374 1056 237 1.80 100 8915 1165 168 731 35
202 F 65 1.56 70.3 29.1 10.0 11.2 1284 2082 798 208 1.62 100 9270 810 84 476 0
203 M 64 1.84 68.2 20.3 10.5 1.8 1568 2855 1287 285 1.82 98 8956 1124 167 784 53
204 M 59 1.73 87.0 29.0 10.5 13.4 1870 3295 1425 329 1.76 98 9088 992 152 606 73
Mean 64 1.71 84.4 28.7 14.2 12.7 1609 2845 1236 284 1.77 99 8990 1090 109 715 34
SD 6 0.09 15.0 4.5 6.4 9.1 243 587 436 59 0.25 1 571 571 148 489 74
Min 43 1.49 49.2 19.6 1.3 1.8 1106 1549 430 155 1.34 87 7140 219 0 78 0
Max 71 1.98 125.5 43.1 34.1 76.1 2285 5023 2982 502 2.55 100 9861 2940 808 2563 542
Additional File 3 
ANALYSIS OF PHYSICAL ACTIVITY IN BOUTS OF 10 MINUTES 
Introduction and Methods 
Some physical activity recommendations refer to the requirement to accumulate physical activity 
in bouts of 10 minutes or more. The 10-minute bout is largely arbitrary and smaller bouts are 
demonstrably important for health. Furthermore, a focus on bouts also introduces the problem of 
how to define what is meant by a bout. For example, three consecutive 8-minute blocks of 
sustained activity with a 2-3 minute gap in between each block might not count towards a bout-
based metric but a single 10-minute block would. Of course, the issue of how to factor in any 
baseline normal lifestyle physical activity still remains even if physical activity is analysed in bouts. 
However, given the prominence of bouts in some recommendations, we used in-house software 
to examine the number of minutes engaged in physical activity above 3 METs in bouts of at least 
10 minutes.  
Results 
On average, participants undertook 287 ± 209 and 715 ± 489 minutes of moderate-to-vigorous 
intensity physical activity in bouts of 10 minutes or more in Comparisons 1 and 2, respectively. 
Based on this analysis, a PAL of 1.75 equates to 292 minutes (Comparison 1) and 683 minutes 
(Comparison 2) of moderate-to-vigorous intensity physical activity (Figure 1S).  A caveat here is 
that the residuals for Comparison 1, in particular, are not well behaved, suggesting problems with 
the specification of the simple linear model. Re-specification of the model as a power function of 
the form Y=aXb improved the fit but made no material difference to the estimate. 
Figure 1S: The relationship between PAL as a standardised measure of physical activity energy 
expenditure (TEE/BMR) and moderate-to-vigorous intensity physical activity in bouts of 10 
minutes or more. Panel A shows the research instrument used in Comparison 1 (n=101) and 
Panel B the commercial instrument used in Comparison 2 (n=204). The regression line with 95% 
CI are included. 
Discussion 
As highlighted in the primary discussion, an analysis of physical activity in bouts of 10 minutes is 
arbitrary and problematic. Nonetheless, it is noteworthy that even in this analysis most 
participants exceeded weekly physical activity recommendations after taking bouts into 
consideration. These results are affected by the same issue of how to factor in baseline physical 
activity (i.e., normal lifestyle activities). According to this analysis, a PAL of 1.75 equates to 
approximately 2-5 fold the recommendation. It is noteworthy that there was a bigger difference 
between devices for this bout-related analysis. Although the reason for this is not fully clear, it is 
likely to be related to the variability (and limitations) of the different types of physiological sensors 
used in these devices. For example, an unresolved issue with temperature and heat flux sensing 
(as used in the BodyMedia FIT device) is the lag time to dissipate heat from the body upon 
completing moderate-to-vigorous intensity activity [1]. This could conceivably extend a given 
bout or mask short gaps between more fragmented activities. As is the case for many commercial 
instruments, the algorithms used in the BodyMedia device are proprietary and thus it is difficult to 
determine if this consideration is a main cause of the reported difference. An alternative 
explanation is that sample-specific differences (e.g., age) could mean that differences in the 
pattern and nature of activity between comparisons could affect bout-related scores. Whatever 
the explanation, this does not affect the overall conclusion that an analysis of activity even after 
factoring in bouts will not be compatible with widely disseminated physical activity 
recommendations. As stated in the primary discussion, this analysis seems less relevant for the 
future because so few commercial monitors provide feedback in the form of bouts and many 
agencies omit bouts in their dissemination of physical activity guidance.  
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